sitagliptin glp 1 agonist GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome Multifaceted Roles of GLP-1 and
Description
Nausea, vomiting, dyspepsia and diarrhea are common side effects
Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses
(March 2021)
Bartness TJ, Vaughan CH, Song CK
The most common scenarios were double doses and doses taken too closely together
